Complement activation in infective endocarditis: Correlation with extracardiac manifestations and prognosis

Clinical and Experimental Immunology

Volumn 127, Issue 2, 2002, Pages 310-315

  Messias Reason, I J ^a,c   Hayashi, S Y ^a   Nisihara, R M ^a   Kirschfink, M ^b  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Laboratorio de Imunopatologia   (Brazil)

Author keywords

Complement; Immune complex; Infective endocarditis

Indexed keywords

COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3A[DEARGININE]; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; AORTA VALVE DISEASE; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD LEVEL; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOELECTROPHORESIS; MALE; MITRAL VALVE DISEASE; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; TURBIDIMETRY;

ADOLESCENT; ADULT; AGED; ANTIGEN-ANTIBODY COMPLEX; BACTEREMIA; CENTRAL NERVOUS SYSTEM DISEASES; COMPLEMENT ACTIVATION; COMPLEMENT C3D; COMPLEMENT MEMBRANE ATTACK COMPLEX; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; KIDNEY DISEASES; LUNG DISEASES; MALE; MIDDLE AGED; PROGNOSIS; RHEUMATOID FACTOR; SPLENOMEGALY;

EID: 0036127557     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01772.x     Document Type: Article

References (42)

1. Risk factor for infective endocarditis
2. Adherence events in pathogenesis of infective endocarditis
3. Experimental bacterial endocarditis II. Survival of bacteria in endocardial vegetations
4. The clinical implications and pathogenetic significance of circulating immune complexes in infective endocarditis
5. Imunopathogenetic aspects of infective endocarditis
6. Fate of circulating immune complexes in infective endocarditis
7. Use of circulating immune complex levels in the serodifferention of endocardic and nonendocarditic septicemias
8. Circulating immune complexes in infective endocarditis
9. Circulating immune complexes in experimental endocarditis. A monitor of therapeutic efficacy
10. Extra cardiac manifestations of bacterial endocarditis
11. Nature of circulating immune complexes in infective endocarditis
12. Serum and tissue immune complexes in infective endocarditis
13. Glomerulonephritis with subacute bacterial endocarditis. Immunofluorescent studies
14. Structure and function of the anaphylatoxins
15. Complement
16. Effect of the late complement components C5b-9 on human monocytes. Release of prostanoids, oxygen radicals and of a factor inducing cell proliferation
17. The Duke endocarditis service. New criteria for the diagnosis of infective endocarditis: Utilization of specific echocardiographic findings
18. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent against a neoantigen of the complex
19. Double-decker rocket immunoeletrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma
20. Evaluation of complement activation in premature newborn infants with hyaline membrane disease
21. Detection and partial characterization of circulating immune complexes with solid-phase anti C3
22. Rheumatoid factor, complement and conglutinin aberrations in patients with subacute bacterial endocarditis
23. Cryoglobulinemia in patients with infectious endocarditis
24. Circulating immune complexes associated with decreased complement-mediated inhibition of immune precipitation in sera from patients with bacterial endocarditis
25. Renal lesions of subacute infective endocarditis
26. The immune complex glomerulonephritis of bacterial endocarditis
27. Complement function and clinical relevance
28. Circulating immune complexes and severe sepsis: Duration of infection as the main determinant
29. Estudios immunologicos en fiebre reumatica activa y endocarditis infecciosa
30. The clinical laboratory: Testing the complement system
31. Infective endocarditis-associated glomerulonephritis in rabbits: Evidence of a pathogenetic role for antiglobulins
32. Vascular disease in infective endocarditis - Report of immune mediated events in skin and brain
33. Splenic immune deposits in bacterial endocarditis
34. Lung injury and complement activation: Role of neutrophils and xantine oxidase
35. Systemic and lung physiological changes in rats after intravascular activation of complement
36. Complement-dependent immune complex-induced bronchial inflammation and hyperreactivity
37. Inhibition of immune precipitation by complement
38. A new complement function: Solubulization of antigen-antibody aggregates
39. Monoclonal rheumatoid factor-IgG immune complexes. Poor fixation of opsonic C4 and C3 despite efficient complement activation
40. Mediators of lung injury in mice following systemic activation of complement
41. Complement (C5a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukocytosis and leukopenia
42. Pulmonary endothelial cell killing by human neutrophils. Possible involvement of hydroxyl radical